Astrazeneca AZN
NYSE AZN
$186.45 -2.94 (-1.55%)
As of: Nov 10, 2026 · 2:20 PM EST

Astrazeneca (AZN) Cash from Restructuring (2009 - 2014)

Updated

Astrazeneca (AZN) recorded Cash from Restructuring of -$13 million in FY2016.

Analysis

Astrazeneca (AZN) Cash from Restructuring (2009 - 2014) Analysis & Trends

Starting with FY2009, Astrazeneca's Cash from Restructuring history includes 7 years.

  • The FY2016 figure is the lowest annual Cash from Restructuring since FY2012.
  • Per Business Quant data, AZN's Cash from Restructuring was -$10 million in FY2014, -$10 million in FY2013 and -$20 million in FY2012.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,264.65 Bn 1,238.27 Bn 20.46 Bn
2 Johnson & Johnson 677.74 Bn 597.60 Bn 17.30 Bn
3 AbbVie 517.10 Bn 485.11 Bn 13.12 Bn
4 Merck 362.23 Bn 325.17 Bn 13.19 Bn
5 Novartis Ag 315.90 Bn 276.16 Bn 11.24 Bn
6 Astrazeneca 289.40 Bn 266.24 Bn 12.86 Bn
7 Amgen 249.90 Bn 201.56 Bn 7.58 Bn
8 Gilead Sciences 209.15 Bn 184.26 Bn 6.73 Bn
9 Pfizer 165.88 Bn 113.23 Bn 12.56 Bn
10 Vertex Pharmaceuticals 138.78 Bn 110.77 Bn 2.91 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2014 85.79 Mn
Mar 31, 2014 -102.00 Mn
Jun 30, 2013 -7.00 Mn
Mar 31, 2013 -3.00 Mn
Sep 30, 2012 1.00 Mn
Jun 30, 2012 -1.00 Mn
Mar 31, 2012 -20.00 Mn
Dec 31, 2011 32.00 Mn
Jun 30, 2011 -1.00 Mn
Mar 31, 2011 -15.00 Mn
Mar 31, 2010 -10.00 Mn
Dec 31, 2009 21.00 Mn
Sep 30, 2009 -20.00 Mn
Jun 30, 2009 1.00 Mn
Mar 31, 2009 9.00 Mn
API Access

Astrazeneca Cash from Restructuring API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-restructuring&ticker=AZN&period=max&api_key=YOUR_API_KEY